Literature DB >> 206291

Reactivity of antiinflammatory and superoxide dismutase active Cu(II)-salicylates.

U Weser, C Richter, A Wendel, M Younes.   

Abstract

The activity of chelated Cu(II) with four different aspirin-like drugs in various superoxide dismutase assays was examined. Prior to these studies the oxidation state of the involved copper was measured by x-ray photoelectron spectrometry and was found to be +II throughout. All copper complexes were able to suppress the xanthine-xanthine oxidase mediated reduction of both cytochrome c and nitroblue tetrazolium as well as the formazan formation by KO2 in a specific manner. The hydroxylation of benzo-[alpha]-pyrene as well as the demethylation of 7-ethoxycoumarin using induced hepatic rat microsomes could be successfully inhibited by the employed Cu(II) chelates. Cu(II)-acetylsalicylate was the most active copper complex. Our findings support the proposal that Cu(II) chelates are the active forms of aspirin-like antiinflammatory agents.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 206291     DOI: 10.1016/s0006-3061(00)80196-9

Source DB:  PubMed          Journal:  Bioinorg Chem        ISSN: 0006-3061


  6 in total

1.  Orally active antioxidative copper(II) aspirinate: synthesis, structure characterization, superoxide scavenging activity, and in vitro and in vivo antioxidative evaluations.

Authors:  T Fujimori; S Yamada; H Yasui; H Sakurai; Y In; T Ishida
Journal:  J Biol Inorg Chem       Date:  2005-10-28       Impact factor: 3.358

2.  Determination of superoxide dismutase-like activity in some divalent metal saccharinates.

Authors:  M C Apella; R Totaro; E J Baran
Journal:  Biol Trace Elem Res       Date:  1993 May-Jun       Impact factor: 3.738

3.  Agents capable of eliminating reactive oxygen species. Catalase, WR-2721, or Cu(II)2(3,5-DIPS)4 decrease experimental colitis.

Authors:  A Keshavarzian; J Haydek; R Zabihi; M Doria; M D'Astice; J R Sorenson
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

4.  Effect of tetrakis-mu-3,5-diisopropylsalicylatodiaquodicopper(II) on the status of reduced glutathione in freshly isolated hepatocytes.

Authors:  M F Khan; Y Ohno; A Takanaka
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

5.  Anti-inflammatory activity of a dermally applied copper salicylate preparation (Alcusal).

Authors:  W R Walker; S J Beveridge; M W Whitehouse
Journal:  Agents Actions       Date:  1980-04

Review 6.  NSAID-Based Coordination Compounds for Biomedical Applications: Recent Advances and Developments.

Authors:  Ariana C F Santos; Luís P G Monteiro; Adriana C C Gomes; Fátima Martel; Teresa M Santos; Bárbara J M Leite Ferreira
Journal:  Int J Mol Sci       Date:  2022-03-05       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.